Abstract
Interpreting pathology specimens is important to the diagnosis of dermatologic disease. This chapter highlights a basic approach to viewing a specimen and understanding important descriptive terminology, immunoperoxidase stains, special stains, and immunofluorescent studies in dermatology.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
When viewing pathology specimens under the microscopic, it is important to first orient yourself to the specimen and then:
-
1.
Be able to differentiate whether it was a shave or punch biopsy
-
2.
Decipher the location based on what you see
-
(a)
Thick stratum corneum and presence of stratum lucidum: acral
-
(b)
Thin skin with loose connective tissue: eyelid
-
(c)
Terminal hair follicles: scalp, axilla vs. vellus hair follicles: face
-
(d)
Sebaceous glands: face
-
(e)
Absent stratum corneum or granulosum: mucosa
-
(a)
-
3.
Visualize all layers present including the epidermis, dermis, subcutaneous fat
-
4.
Locate areas with main pathology
Descriptive Terms | |||
Term | Description | ||
Acantholysis | Separation of epidermal keratinocytes due to destruction of desmosomes | ||
Acanthosis | Hyperplasia of epidermis | ||
Atrophy | Chronic degeneration of the epidermis or dermis resulting in thinning and fragility of structure | ||
Dyskeratosis | Abnormal keratinization of a keratinocyte while the cell is still in the epidermis | ||
Epidermotropism | The propensity of malignant lymphocytes to migrate into the epidermis without significant spongiosis | ||
Exocytosis | The presence of inflammatory cells, such as benign lymphocytes, neutrophils or eosinophils, within the epidermis during an inflammatory reaction | ||
Fibrosis | An increase in both individual collagen fiber thickness and in overall collagen density within the dermis | ||
Hyperkeratosis | An increase in the thickness of the stratum corneum | ||
Interface changes | Constellation of changes seen at the dermoepidermal junction in interface dermatitis, including formation of vacuoles in the basal keratinocytes, dying individual keratinocytes, and lymphocyte exocytosis | ||
Interstitial | Located in the spaces between the collagen and elastic fibers of the dermis | ||
Lichenoid | Having a band-like infiltrate of inflammatory cells (usually lymphocytes) directly beneath the epidermis and masking the dermoepidermal junction | ||
Papillomatosis | Undulating epidermal projections resembling fingers or church spires | ||
Parakeratosis | Retention of the nucleus within the stratum corneum cells instead of loss of the nucleus | ||
Pigment incontinence | Loss of melanin, which is normally found in epidermal keratinocytes and melanocytes, into the dermis where it is phagocytosed by melanophages | ||
Pseudoepitheliomatous hyperplasia | Marked irregular acanthosis of the epidermis that is so severe as to mimic squamous cell carcinoma | ||
Psoriasiform | Having epidermal hyperplasia featuring long, thin, regular rete ridges that resemble those seen in classic plaque-type psoriasis | ||
Solar elastosis | Gray-blue discoloration of superficial dermal elastic fibers secondary to sun damage | ||
Spongiosis | Edema between epidermal keratinocytes, pushing them apart and straining intercellular bridges | ||
Vasculitis | Endothelial cell swelling, fibrinoid necrosis of the vessel wall, and infiltration of the vessel wall by inflammatory cells | ||
Vasculopathy | Any abnormality of the vessel wall that does not meet the criteria of vasculitis | ||
Melanocytic Markers | |||
Marker | Pattern of Staining | Cell Types Positive | Common Uses in Dermpath |
S-100 | Nucleus & cytoplasm | Melanocytes, nerve sheath cells, some histiocytes | Melanocytic nevi and melanoma, neural tumors, Langerhans cells, granular cell tumors, Rosai-Dorfman disease |
MART-1 (Melan-A) | Cytoplasm | Melanocytes | Melanocytic nevi and melanoma |
SOX-10 | Nucleus | Melanocytes, nerve sheath cells | Melanocytic nevi and melanoma, neural tumors |
MiTF | Nucleus | Melanocytes, nerve sheath cells | Melanocytic nevi and melanoma |
HMB-45 | Cytoplasm | Melanocytes | Melanocytic nevi and melanoma |
Epithelial markers | |||
Marker | Pattern of staining | Cell types positive | Common uses in Dermpath |
High Molecular Weight Cytokeratins | Cytoplasm | Epithelial cells of epidermis, hair follicle, sebaceous gland, eccrine and apocrine ducts | BCC and SCC (+), adnexal tumors variable |
Low Molecular Weight Cytokeratins | Cytoplasm | Epithelial cells of epidermis, hair follicle, sebaceous gland, eccrine and apocrine glands | Adnexal tumors (+), metastatic carcinoma usually (+) |
CAM5.2 | Cytoplasm | Epithelial cells of epidermis, hair follicle, sebaceous gland, eccrine and apocrine glands | Eccrine and apocrine secretory coils (+), Paget’s disease (+), SCC (−) |
Epithelial Membrane Antigen (EMA) | Cytoplasm | Epithelial cells and ducts of sebaceous gland, eccrine and apocrine glands | (+) in SCC, sebaceous tumors, and eccrine and apocrine adnexal tumors, (−) in BCC |
Carcinoembryonic Antigen (CEA) | Ductal/luminal cytoplasm | Ductal/luminal surfaces of eccrine and apocrine ducts and glands | Identifying ductal differentiation in tumors such as microcystic adnexal carcinoma (+) |
BerEP4 | Cell membrane | Epithelial cells of some vellus hair follicles, eccrine and apocrine coils | Distinguishing BCC (+) from SCC (−) and microcystic adnexal carcinoma (−) |
P63 | Nucleus | Epithelial cells of epidermis, hair follicle, myoepithelial cells of eccrine and apocrine glands and ducts | SCC (+), distinguishing primary skin adnexal tumors (+) from metastatic adenocarcinoma (−) |
Mesenchymal markers | |||
Marker | Pattern of staining | Cell types positive | Common uses in Dermpath |
Factor XIIIa | Cytoplasm | Dermal dendritic cells, fibroblasts | Dermatofibroma (+) vs. dermatofibrosarcoma protuberans (−) |
CD34 | Cytoplasm | Endothelial cells, dermal dendritic cells | Vascular tumors, dermatofibrosarcoma protuberans, spindle cell lipoma |
CD31 | Cytoplasm | Endothelial cells | Vascular tumors |
D2–40 | Cytoplasm | Endothelial cells of lymphatics | Lymphatic tumors |
SMA | Cytoplasm | Smooth muscle, myofibroblasts | Smooth muscle tumors, nodular fasciitis, glomus tumor |
Desmin | Cytoplasm | Smooth and skeletal muscle | Tumors of smooth and skeletal muscle |
Vimentin | Cytoplasm | All cell types of mesenchymal derivation | Usually carcinoma (−), sarcoma (+) |
Neuron-specific Enolase | Cytoplasm | Nerves and neuroendocrine cells | Identifying neural and neuroendocrine tumors such as granular cell tumor (+) |
Hematopoietic markers | |||
Marker | Pattern of staining | Cell types positive | Common uses in Dermpath |
CD45/LCA | Membrane/cytoplasm | Lymphocytes, neutrophils, eosinophils, histiocytes, plasma cells | Establish the hematopoietic origin of a tumor/infiltrate |
CD3 | Membrane/cytoplasm | T-lymphocytes | Identifying T-lymphocytes |
CD20 | Membrane/cytoplasm | B-lymphocytes | Identifying B-lymphocytes |
CD4 | Membrane/cytoplasm | Helper T-lymphocytes | Identifying helper T-lymphocytes |
CD5 | Membrane/cytoplasm | T-lymphocytes | T cell marker, loss of CD5 can indicate possible malignancy |
CD7 | Membrane/cytoplasm | T-lymphocytes | T cell marker, loss of CD7 can indicate possible malignancy |
CD8 | Membrane/cytoplasm | Cytotoxic T-lymphocytes | Identifying cytotoxic T-lymphocytes |
CD30 | Membrane/cytoplasm | Activated T-lymphocytes and neoplastic T-lymphocytes | Increased expression in lymphomatoid papulosis and anaplastic large T-cell lymphoma |
CD68 | Membrane/cytoplasm | Histiocytes/macrophages | Identifying histiocytes |
CD38/138 | Membrane/cytoplasm | Plasma cells | Identifying plasma cells |
CD56 | Membrane/cytoplasm | NK/T cells, neuroendocrine cells | Identifying NK-cell differentiation, also in neuroendocrine tumors |
BCL-2 | Cytoplasm | T-lymphocytes, B-lymphocytes outside of germinal centers | Marginal zone lymphoma, diffuse large B-cell lymphoma, absent in most cases of primary cutaneous follicle center lymphoma vs. strong positive reaction in nodal follicular lymphoma |
BCL-6 | Nucleus | B-lymphocytes within germinal centers, some T-lymphocytes | Follicle center lymphoma |
CD10 | Membrane/cytoplasm | Germinal center B-cells, sebaceous glands | Follicle center lymphoma (+), also (+) in atypical fibroxanthoma and clear cell renal cell carcinoma |
MUM-1 | Nucleus | Plasma cells and post-germinal center B-lymphocytes | Diffuse large B-cell lymphoma, myeloma |
Kappa light chain | Cytoplasm | Plasma cells | Marginal zone lymphoma |
Lambda light chain | Cytoplasm | Plasma cells | Marginal zone lymphoma |
ALK-1 | Nucleus and cytoplasm | Anaplastic large T-cell lymphoma (ALCL) cells | Usually systemic ALCL (+) vs. primary cutaneous ALCL (−) |
Miscellaneous IHC markers | |||
Marker | Pattern of staining | Cell types positive | Common uses in Dermpath |
CK7 | Cytoplasm | Tissue of breast, lung, upper GI tract and bladder | Identifying adenocarcinomas of breast, lung, upper GI tract and bladder, (+) in Toker cells, mammary and extramammary Paget’s disease |
CK20 | Cytoplasm | Merkel cells, adenocarcinomas of colon, bladder and bile ducts | Merkel cell carcinoma, identifying adenocarcinomas of colon, some cases of extramammary Paget’s disease secondary to underlying carcinomas |
CD1a | Membrane/cytoplasm | Langerhans cells | Identifying Langerhans cells |
CD117 (c-kit) | Membrane/cytoplasm | Mast cells | Identifying mast cells |
TTF-1 | Nuclear | Lung carcinoma, thyroid carcinoma | Thyroid cancer, distinguishing between small cell carcinoma of the lung and Merkel cell carcinoma |
Adipophilin | Perivacuolar | Sebaceous gland cells | Establishing sebaceous differentiation in a tumor, sebaceous tumors |
GCDFP-15 | Cytoplasm | Breast ducts | Identifying breast carcinoma, mammary and extramammary Paget’s disease |
Chromogranin | Cytoplasm | Neuroendocrine cells and tumors | Identifying neuroendocrine tumors such as Merkel cell carcinoma |
Synaptophysin | Cytoplasm | Neuroendocrine cells and tumors | Identifying neuroendocrine tumors such as Merkel cell carcinoma |
Special stains | |||
Marker | Material staining | Color of positive stain | Common uses in Dermpath |
PAS | Fungal structures, basement membrane, glycogen, epithelial mucins | Dark pink/red | Dermatophytes and deep fungal infections |
GMS | Fungal structures | Black | Fungal infections |
Alcian Blue | Stromal/mesenchymal mucin | Bright blue | Dermal mucin deposition |
Colloidal Iron | Mucins, some stromal and some epithelial | Blue | Dermal mucin deposition |
Masson Trichrome | Stain that highlights collagen and muscle | Collagen: blue/green, muscle fibers/keratin: red | Identifying collagen and fibrosis |
Fontana Masson | Melanin | Black granules | Distinguishing between hemosiderin (−) and melanin pigment (+) |
Perl’s Prussian Blue | Iron/hemosiderin | Blue granules | Distinguishing between hemosiderin (+) and melanin pigment (−) |
Chloroacetate esterase (Leder stain) | Mast cell granules | Purple | Identifying mast cells |
Gram | Bacteria | Gram+ organisms: dark blue/purple, Gram- organisms: red | Identifying bacteria |
Fite | Mycobacteria | Red | Identifying mycobacteria |
Warthin Starry | Spirochetes, some bacteria | Black | Syphilis, bacillary angiomatosis |
Toluidine Blue | Mast cells, mucin | Mast cells: purple, mucin: purple/red | Identifying mast cells |
Congo Red | Amyloid | Red/orange | Identifying amyloid |
Crystal Violet | Amyloid | Violet/purple | Identifying amyloid |
Verhoeff-Van Gieson | Elastin | Black | Identifying elastic fibers |
Von Kossa | Calcium | Black | Identifying calcium, calciphylaxis, pseudoxanthoma elasticum |
Oil Red O | Lipid (fresh or frozen tissue only) | Red | Identifying lipids and fat |
Sudan Black B | Lipid | Black | Identifying lipids and fat |
Giemsa | Mast cells | Dark blue/purple | Identifying mast cells |
Immunofluorescence Studies
Direct immunofluorescence (DIF): An antibody directly detects presence of a pathologic antibody in the skin
Indirect immunofluorescence (IIF): Serum is introduced to a substrate in order to detect circulating antibodies
Salt-split skin test: with NaCl, skin is cleaved at lamina lucida at BMZ – Allows separation of roof/floor fluorescence
Biopsy sites for DIF: autoimmune blistering diseases – inflamed but unblistered perilesional skin, autoimmune and inflammatory diseases other than blistering diseases – lesional skin, vasculitis- 1 to 2 day-old fresh lesional skin
Disease | Pattern of DIF Staining | Salt Split IF |
---|---|---|
Pemphigus vulgaris | IgG and occasional C3 in the intercellular region of the epidermis | |
Pemphigus foliaceus | IgG and occasional C3 in the intercellular region of the epidermis | |
Pemphigus erythematosus | Intercellular and basement membrane staining with IgG and/or C3 | |
Paraneoplastic pemphigus | Intercellular and basement membrane staining with IgG and/or C3 | |
IgA pemphigus | Intercellular deposition of IgA in the epidermis | |
Bullous pemphigoid | Linear, homogeneous deposition of IgG and/or C3 at the BMZ | Roof |
Epidermolysis bullosa acquisita | Linear deposition of IgG (les commonly C3, IgA or IgM) at the BMZ | Floor |
Bullous SLE | IgG (less commonly IgA, IgM) and complement at the BMZ | Floor |
Mucous membrane pemphigoid | Linear deposit of IgG (and sometimes IgA) and C3 at the BMZ | Roof/Floor |
Linear IgA bullous dermatosis | Homogeneous linear pattern of IgA deposition at the BMZ | Roof/Floor |
Dermatitis herpetiformis | Granular deposits of IgA in the dermal papillae | |
Porphyria cutanea tarda | Ig, complement and fibrinogen at the BMZ and around blood vessels | |
Henoch-Schönlein purpura | IgA (usually fibrinogen and C3 as well) deposition in blood vessels | |
Lichen planus | Shaggy deposits of fibrin at the BMZ |
References
Molina-Ruiz AM, Fuertes L, Requena L. Immunohistology and molecular studies of sweat gland tumors. In: Plaza JA, Prieto VG, editors. Applied immunohistochemistry in the evaluation of skin neoplasms. Switzerland: Springer International Publishing Switzerland; 2016.
Sanders DSA, Carr RA. The use of immunohistochemistry in the differential diagnosis of common epithelial tumors of the skin. Curr Diagn Pathol. 2007;13:237–51.
Compton LA, Murphy GF, Lian CG. Diagnostic immunohistochemistry in cutaneous neoplasia: an update. Dermatopathology. 2015;2:15–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Barrett, M.M., Vashi, N.A., Chung, H.J. (2019). An approach to Dermatopathology: Immunohistochemical and special stains. In: Vashi, N. (eds) The Dermatology Handbook. Springer, Cham. https://doi.org/10.1007/978-3-030-15157-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-15157-7_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15156-0
Online ISBN: 978-3-030-15157-7
eBook Packages: MedicineMedicine (R0)